Literature DB >> 20547796

Staphylococcus aureus TargetArray: comprehensive differential essential gene expression as a mechanistic tool to profile antibacterials.

H Howard Xu1, John D Trawick, Robert J Haselbeck, R Allyn Forsyth, Robert T Yamamoto, Rich Archer, Joe Patterson, Molly Allen, Jamie M Froelich, Ian Taylor, Danny Nakaji, Randy Maile, G C Kedar, Marshall Pilcher, Vickie Brown-Driver, Melissa McCarthy, Amy Files, David Robbins, Paula King, Susan Sillaots, Cheryl Malone, Carlos S Zamudio, Terry Roemer, Liangsu Wang, Philip J Youngman, Daniel Wall.   

Abstract

The widespread emergence of antibiotic-resistant bacteria and a lack of new pharmaceutical development have catalyzed a need for new and innovative approaches for antibiotic drug discovery. One bottleneck in antibiotic discovery is the lack of a rapid and comprehensive method to identify compound mode of action (MOA). Since a hallmark of antibiotic action is as an inhibitor of essential cellular targets and processes, we identify a set of 308 essential genes in the clinically important pathogen Staphylococcus aureus. A total of 446 strains differentially expressing these genes were constructed in a comprehensive platform of sensitized and resistant strains. A subset of strains allows either target underexpression or target overexpression by heterologous promoter replacements with a suite of tetracycline-regulatable promoters. A further subset of 236 antisense RNA-expressing clones allows knockdown expression of cognate targets. Knockdown expression confers selective antibiotic hypersensitivity, while target overexpression confers resistance. The antisense strains were configured into a TargetArray in which pools of sensitized strains were challenged in fitness tests. A rapid detection method measures strain responses toward antibiotics. The TargetArray antibiotic fitness test results show mechanistically informative biological fingerprints that allow MOA elucidation.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20547796      PMCID: PMC2934999          DOI: 10.1128/AAC.00308-10

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  56 in total

1.  dnaB protein of Escherichia coli. Purification and role in the replication of phiX174 DNA.

Authors:  K Ueda; R McMacken; A Kornberg
Journal:  J Biol Chem       Date:  1978-01-10       Impact factor: 5.157

2.  Polar allele duplication for transcriptional analysis of consecutive essential genes: application to a cluster of Escherichia coli fatty acid biosynthetic genes.

Authors:  Y Zhang; J E Cronan
Journal:  J Bacteriol       Date:  1996-06       Impact factor: 3.490

3.  Functional analysis of a palindromic sequence required for normal replication of several staphylococcal plasmids.

Authors:  A D Gruss; H F Ross; R P Novick
Journal:  Proc Natl Acad Sci U S A       Date:  1987-04       Impact factor: 11.205

4.  Properties of a cryptic high-frequency transducing phage in Staphylococcus aureus.

Authors:  R Novick
Journal:  Virology       Date:  1967-09       Impact factor: 3.616

5.  Promoters recognized by Escherichia coli RNA polymerase selected by function: highly efficient promoters from bacteriophage T5.

Authors:  R Gentz; H Bujard
Journal:  J Bacteriol       Date:  1985-10       Impact factor: 3.490

6.  The toxic shock syndrome exotoxin structural gene is not detectably transmitted by a prophage.

Authors:  B N Kreiswirth; S Löfdahl; M J Betley; M O'Reilly; P M Schlievert; M S Bergdoll; R P Novick
Journal:  Nature       Date:  1983 Oct 20-26       Impact factor: 49.962

7.  Isolation, structure, and absolute stereochemistry of platensimycin, a broad spectrum antibiotic discovered using an antisense differential sensitivity strategy.

Authors:  Sheo B Singh; Hiranthi Jayasuriya; John G Ondeyka; Kithsiri B Herath; Chaowei Zhang; Deborah L Zink; Nancy N Tsou; Richard G Ball; Angela Basilio; Olga Genilloud; Maria Teresa Diez; Francisca Vicente; Fernando Pelaez; Katherine Young; Jun Wang
Journal:  J Am Chem Soc       Date:  2006-09-13       Impact factor: 15.419

8.  Quantitative phenotypic analysis of yeast deletion mutants using a highly parallel molecular bar-coding strategy.

Authors:  D D Shoemaker; D A Lashkari; D Morris; M Mittmann; R W Davis
Journal:  Nat Genet       Date:  1996-12       Impact factor: 38.330

9.  Identification and nucleotide sequence of the class E tet regulatory elements and operator and inducer binding of the encoded purified Tet repressor.

Authors:  K Tovar; A Ernst; W Hillen
Journal:  Mol Gen Genet       Date:  1988-12

10.  The mechanism of action of fosfomycin (phosphonomycin).

Authors:  F M Kahan; J S Kahan; P J Cassidy; H Kropp
Journal:  Ann N Y Acad Sci       Date:  1974-05-10       Impact factor: 5.691

View more
  30 in total

Review 1.  Bugs, drugs and chemical genomics.

Authors:  Terry Roemer; Julian Davies; Guri Giaever; Corey Nislow
Journal:  Nat Chem Biol       Date:  2011-12-15       Impact factor: 15.040

Review 2.  Genetic Approaches to Facilitate Antibacterial Drug Development.

Authors:  Dirk Schnappinger
Journal:  Cold Spring Harb Perspect Med       Date:  2015-02-13       Impact factor: 6.915

3.  Systems-level antimicrobial drug and drug synergy discovery.

Authors:  Terry Roemer; Charles Boone
Journal:  Nat Chem Biol       Date:  2013-04       Impact factor: 15.040

4.  A genome-wide inducible phenotypic screen identifies antisense RNA constructs silencing Escherichia coli essential genes.

Authors:  Jia Meng; Gregory Kanzaki; Diane Meas; Christopher K Lam; Heather Crummer; Justina Tain; H Howard Xu
Journal:  FEMS Microbiol Lett       Date:  2012-02-10       Impact factor: 2.742

5.  Classifying compound mechanism of action for linking whole cell phenotypes to molecular targets.

Authors:  Christina R Bourne; Nancy Wakeham; Richard A Bunce; Baskar Nammalwar; K Darrell Berlin; William W Barrow
Journal:  J Mol Recognit       Date:  2012-04       Impact factor: 2.137

6.  Competitive Growth Enhances Conditional Growth Mutant Sensitivity to Antibiotics and Exposes a Two-Component System as an Emerging Antibacterial Target in Burkholderia cenocepacia.

Authors:  April S Gislason; Matthew Choy; Ruhi A M Bloodworth; Wubin Qu; Maria S Stietz; Xuan Li; Chenggang Zhang; Silvia T Cardona
Journal:  Antimicrob Agents Chemother       Date:  2016-12-27       Impact factor: 5.191

7.  A Comprehensive, CRISPR-based Functional Analysis of Essential Genes in Bacteria.

Authors:  Jason M Peters; Alexandre Colavin; Handuo Shi; Tomasz L Czarny; Matthew H Larson; Spencer Wong; John S Hawkins; Candy H S Lu; Byoung-Mo Koo; Elizabeth Marta; Anthony L Shiver; Evan H Whitehead; Jonathan S Weissman; Eric D Brown; Lei S Qi; Kerwyn Casey Huang; Carol A Gross
Journal:  Cell       Date:  2016-05-26       Impact factor: 41.582

Review 8.  Human body temperature and new approaches to constructing temperature-sensitive bacterial vaccines.

Authors:  Matthew D White; Catharine M Bosio; Barry N Duplantis; Francis E Nano
Journal:  Cell Mol Life Sci       Date:  2011-05-31       Impact factor: 9.261

9.  Broadening the spectrum of β-lactam antibiotics through inhibition of signal peptidase type I.

Authors:  Alex G Therien; Joann L Huber; Kenneth E Wilson; Patrick Beaulieu; Alexandre Caron; David Claveau; Kathleen Deschamps; Robert G K Donald; Andrew M Galgoci; Michel Gallant; Xin Gu; Nancy J Kevin; Josiane Lafleur; Penny S Leavitt; Christian Lebeau-Jacob; Suzy S Lee; Molly M Lin; Anna A Michels; Aimie M Ogawa; Ronald E Painter; Craig A Parish; Young-Whan Park; Liliana Benton-Perdomo; Mihai Petcu; John W Phillips; Mary Ann Powles; Kathryn I Skorey; John Tam; Christopher M Tan; Katherine Young; Simon Wong; Sherman T Waddell; Lynn Miesel
Journal:  Antimicrob Agents Chemother       Date:  2012-06-18       Impact factor: 5.191

10.  Myxobacterium-produced antibiotic TA (myxovirescin) inhibits type II signal peptidase.

Authors:  Yao Xiao; Klaus Gerth; Rolf Müller; Daniel Wall
Journal:  Antimicrob Agents Chemother       Date:  2012-01-09       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.